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Editorial on the Research Topic
Meeting of the Portuguese Society for Neurosciences SPN2019
The Portuguese Society for Neuroscience meeting (SPN2019) was held in Lisbon from 30th May
to 1st June, 2019. The main purpose of this meeting was to promote and develop research in
Neurosciences. This interaction took place in a privileged way at this meeting and brought together
the vibrant Portuguese Neuroscience community that significantly advances this defying area.
This Research Topic comprises nine manuscripts covering some of the work presented
at SPN2019 and hot topics in neurosciences: neurodevelopment; cellular and molecular
neurosciences; neurodegeneration; glia and neuroinflammation; drug and addiction; sensory
processing; and rare disorders.
In a brief Research Report, Miranda et al. show that cannabidiol, 19-tetrahydrocannabinol,
and two synthetic cannabinoids (THJ-018 and EG-018) profoundly impact, from toxicity to
precocity, developing neurons, highlighting the negative effect of prenatal exposure to natural and
synthetic cannabinoids.
A brief Research Report by Neiva et al. shows that methylprednisolone differentially affects
GABA and glutamate release from rat hippocampal nerve terminals via fast non-genomic
mechanisms putatively involving the activation of membrane-bound corticosteroid receptors.
Original Research by Sa de Almeida et al. reveals that microglial Sirtuin 2 (Sirt2) prevents
NMDA-mediated excitotoxicity in hippocampal slices in response to an inflammatory signal.
Overall, the data suggest a key-protective role for microglial Sirt2 in amnesic deficits associated
with neuroinflammation.
Original Research by Fonteles et al. supports that antagonists of ATP receptors P2X7 are
protective of dyskinesia induced by dopamine replacement therapy in a Parkinson’s disease rat
model. These findings suggest P2X7 antagonists as novel candidate anti-dyskinesia drugs.
Original Research by Costa-Pereira et al. describes an enhancement of the descending
noradrenergic pain control system due to neuropathy induced by cancer chemotherapy. The
authors suggest that potentiation of the antinociception mediated by alpha2-adrenoreceptors may
be a therapeutic opportunity.
Original Research by Fabricio de Sousa et al. shows that the cerebellum is vulnerable tometabolic
changes due to ultra-endurance racer. High-volume training in rodents induced cerebellar
oxidative and inflammatory status and impaired astrocyte reactivity.
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Mouro et al. reviewed the recent evidence concerning
metabolic, synaptic, functional, and molecular dysfunctions
occurring in Rett syndrome. From modulators of GABAergic
signaling to cannabinoids and the ketogenic diet, cleverly
exploiting the metabolic features of this disease, an ample bulk of
evidence has been gathered, creating a plethora of research lines
to be followed in the future.
Perdigão et al. reviewed the intracellular trafficking
mechanisms of synaptic dysfunction in Alzheimer’s disease.
They described that in early and late-onset familial Alzheimer’s
disease the earliest synaptic dysfunctions are characterized by
disruptions of the presynaptic vesicle exo- and endocytosis
and postsynaptic glutamate receptor endocytosis. While in
early-onset familial Alzheimer’s disease, synapse dysfunction
seems to be triggered by Aβ, in late-onset Alzheimer’s disease,
there might be a direct synaptic disruption by late-onset
Alzheimer’s disease trafficking genes, requiring further research.
Themini-review by Gonçalves-Ribeiro et al. discussed the role
of the increase in glutamate uptake on hippocampal long-term
potentiation and depression beyond excitotoxicity.
Overall, this Research Topic compiling both original and
review papers shows the diversity in the neuroscience field
ranging from in vitro to in vivo approaches, including rare to
common disorders, neurodevelopment to aging, and molecular
to behavioral tests. We hope this collection of articles will be
highly attractive to the international neuroscience community.
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